Summary
Glucagon-like peptide-1 and glucagon-like peptide-2 are encoded by the m-RNA of pancreatic preproglucagon. They show high conservation in different species and substantial sequence homology to glucagon. Because no definite biological activity of these peptides has been reported, we investigated the effect of synthetic C-terminally amidated glucagon-like peptide-1 [1–36] and synthetic human glucagon-like peptide-2 [1–34] with a free C-terminus on insulin release from isolated precultured rat pancreatic islets in the presence of glucose. Glucagon-like peptide-1 stimulates insulin release at 10 and 16.7 mmol/l glucose in a dose-dependent manner. Significant stimulation starts at 2.5 nmol/l in the presence of 10 mmol/l glucose and near maximal release is observed at 250 nmol/l, with approximately 100% increase over basal at both glucose concentrations. The peptide reaches 63% of the maximal stimulatory effect of glucagon. No stimulation occurs in the presence of 2.8 mmol/l glucose. Glucagon-like peptide-2 has no effect on insulin secretion at any glucose concentration tested. It is concluded that glucagon-like peptide-1, in contrast to glucagon-like peptide-2, exhibits a glucose-dependent insulinotropic action on isolated rat pancreatic islets similar to that of glucagon and gastric inhibitory polypeptide.
Article PDF
Similar content being viewed by others
References
Lund PK, Goodman RH, Dee PC, Habener JF (1982) Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem. Proc Natl Acad Sci USA 79: 345–349
Bell GI, Santerre RF, Mullenbach GT (1983) Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302: 716–718
Lopez LC, Frazier ML, Su CJ, Kumar A, Saunders GF (1983) Mammalian pancreatic preproglucagon contains three glucagonrelated peptides. Proc Natl Acad Sci USA 80: 5484–5489
Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC (1983) Exon duplication and divergence in the human preproglucagon gene. Nature 304: 368–371
Heinrich G, Gros P, Habener JF (1984) Glucagon gene sequence — Four of six exons encode separate functional domains of rat preproglucagon. J Biol Chem 259: 14082–14087
Uttenthal LO, Ghiglione M, George SK, Bloom SR (1984) Radioimmunoassay for glucagon-like peptide-1: presence in human pancreas and glucagonomas. Diabetologia 27: 341 (Abstract)
Hossein NM, Gurd RS (1984) Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett 178: 83–86
Uttenthal LO, Ghiglione M, George SK, Bloom SR(1984) Effect of glucagon-like peptide-1 (GLP-1) on pancreatic juice output in the rat. Dig Dis Sci 29: 91S (Abstract)
Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35–39
Siegel EG, Wollheim CB, Renold AE (1980) Evidence for the involvement of Na/Ca-exchange in glucose-induced insulin release from rat pancreatic islets. J Clin Invest 66: 996–1003
Siegel EG, Creutzfeldt W (1984) Stimulation of insulin release and cyclic AMP content by physiological levels of GIP in isolated islets. Europ J Clin Invest 14II: 283 (Abstract)
Melani F, Ditschuneit H, Bartelt KM, Friedrich H, Pfeiffer EF (1965) Über dieradioimmunologische Bestimmung von Insulin im Blut. Klin Wochenschr 43: 1000–1007
Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6: 65–70
Schauder P, Brown JC, Frerichs H, Creutzfeldt W (1975) Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro. Diabetologia 11: 483–484
Dupre J, Ross SA, Watson D, Brown JC (1973) Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metabol 37: 826–829
Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R (1978) Oral glucose augmentation of insulin secretion. Interaction of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest 62: 152–161
Moody AJ, Thim L, Valverde I (1984) The isolation and sequencing of human gastric inhibitory polypeptide (GIP). FEBS Lett 172: 142–148
Holst JJ (1983) Gut glucagon, enteroglucagon, gut glucagon-like immunoreactivity, glicentin — current status. Gastroenterology 84: 1602–1613
Maletti M, Portha B, Carlquist M, Kergoat M, Laburthe M, Marie JC, Rosselin G (1984) Evidence for and characterization of specific high affinity binding sites for the gastric inhibitory polypeptide in pancreatic β-cells. Endocrinology 115: 1324–1331
Ghiglione M, Uttenthal LO, George SK, Bloom SR (1984) How glucagon-like is glucagon-like peptide-1? Diabetologia 27: 599–600
Patzelt C, Schiltz E (1984) Conversion of proglucagon in pancreatic alpha cells: The major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two gluagon-like sequences. Proc Natl Acad Sci USA 81: 5007–5011
Creutzfeldt W (1979) The incretin concept today. Diabetologia 16: 75–85
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, W.E., Siegel, E.G. & Creutzfeldt, W. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28, 704–707 (1985). https://doi.org/10.1007/BF00291980
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00291980